nodes	percent_of_prediction	percent_of_DWPC	metapath
Pravastatin—SLCO1B3—Mycophenolate mofetil—psoriasis	0.0434	0.056	CbGbCtD
Pravastatin—ABCB11—Cyclosporine—psoriasis	0.032	0.0413	CbGbCtD
Pravastatin—SLC16A1—Methotrexate—psoriasis	0.0312	0.0402	CbGbCtD
Pravastatin—CYP2C8—Tazarotene—psoriasis	0.0289	0.0373	CbGbCtD
Pravastatin—CYP3A5—Beclomethasone—psoriasis	0.0279	0.0361	CbGbCtD
Pravastatin—SLCO1B1—Mycophenolate mofetil—psoriasis	0.0253	0.0326	CbGbCtD
Pravastatin—SLCO1A2—Prednisolone—psoriasis	0.0227	0.0293	CbGbCtD
Pravastatin—ABCC2—Mycophenolate mofetil—psoriasis	0.0222	0.0287	CbGbCtD
Pravastatin—SLCO1A2—Hydrocortisone—psoriasis	0.0215	0.0277	CbGbCtD
Pravastatin—SLCO1A2—Prednisone—psoriasis	0.0214	0.0276	CbGbCtD
Pravastatin—ABCB11—Dexamethasone—psoriasis	0.0211	0.0272	CbGbCtD
Pravastatin—SLCO1A2—Cyclosporine—psoriasis	0.0203	0.0262	CbGbCtD
Pravastatin—ABCG2—Mycophenolate mofetil—psoriasis	0.0201	0.0259	CbGbCtD
Pravastatin—SLCO1B1—Cyclosporine—psoriasis	0.0191	0.0247	CbGbCtD
Pravastatin—SLCO1B3—Methotrexate—psoriasis	0.0174	0.0225	CbGbCtD
Pravastatin—ABCC2—Cyclosporine—psoriasis	0.0168	0.0217	CbGbCtD
Pravastatin—ABCG2—Hydrocortisone—psoriasis	0.0161	0.0208	CbGbCtD
Pravastatin—SLC22A11—Methotrexate—psoriasis	0.0161	0.0208	CbGbCtD
Pravastatin—SLC22A7—Methotrexate—psoriasis	0.0153	0.0198	CbGbCtD
Pravastatin—ABCG2—Cyclosporine—psoriasis	0.0152	0.0196	CbGbCtD
Pravastatin—SLCO1A2—Dexamethasone—psoriasis	0.0134	0.0173	CbGbCtD
Pravastatin—CYP2D6—Hydroxyurea—psoriasis	0.013	0.0168	CbGbCtD
Pravastatin—CYP2C8—Cholecalciferol—psoriasis	0.0123	0.0159	CbGbCtD
Pravastatin—SLC22A6—Cyclosporine—psoriasis	0.0123	0.0159	CbGbCtD
Pravastatin—CYP3A5—Mycophenolate mofetil—psoriasis	0.0111	0.0144	CbGbCtD
Pravastatin—ABCC2—Dexamethasone—psoriasis	0.0111	0.0143	CbGbCtD
Pravastatin—SLCO1A2—Methotrexate—psoriasis	0.0107	0.0139	CbGbCtD
Pravastatin—CYP2C8—Mycophenolate mofetil—psoriasis	0.0107	0.0138	CbGbCtD
Pravastatin—SLCO1B1—Methotrexate—psoriasis	0.0101	0.0131	CbGbCtD
Pravastatin—ABCG2—Dexamethasone—psoriasis	0.01	0.0129	CbGbCtD
Pravastatin—CYP3A4—Calcitriol—psoriasis	0.00971	0.0125	CbGbCtD
Pravastatin—SLC22A8—Methotrexate—psoriasis	0.00935	0.0121	CbGbCtD
Pravastatin—CYP3A5—Hydrocortisone—psoriasis	0.00892	0.0115	CbGbCtD
Pravastatin—ABCC2—Methotrexate—psoriasis	0.0089	0.0115	CbGbCtD
Pravastatin—CYP2C9—Cholecalciferol—psoriasis	0.0086	0.0111	CbGbCtD
Pravastatin—CYP2C8—Hydrocortisone—psoriasis	0.00858	0.0111	CbGbCtD
Pravastatin—CYP3A5—Cyclosporine—psoriasis	0.00843	0.0109	CbGbCtD
Pravastatin—CYP2C8—Cyclosporine—psoriasis	0.0081	0.0105	CbGbCtD
Pravastatin—ABCG2—Methotrexate—psoriasis	0.00805	0.0104	CbGbCtD
Pravastatin—CYP2D6—Cholecalciferol—psoriasis	0.00786	0.0102	CbGbCtD
Pravastatin—CYP3A4—Methoxsalen—psoriasis	0.00755	0.00975	CbGbCtD
Pravastatin—Lovastatin—ITGAL—psoriasis	0.00736	1	CrCbGaD
Pravastatin—ABCB1—Mycophenolate mofetil—psoriasis	0.00724	0.00934	CbGbCtD
Pravastatin—SLC22A6—Methotrexate—psoriasis	0.00651	0.00841	CbGbCtD
Pravastatin—ABCB1—Betamethasone—psoriasis	0.00621	0.00802	CbGbCtD
Pravastatin—ABCB1—Prednisolone—psoriasis	0.00613	0.00791	CbGbCtD
Pravastatin—ABCB1—Hydrocortisone—psoriasis	0.00581	0.0075	CbGbCtD
Pravastatin—ABCB1—Prednisone—psoriasis	0.00579	0.00747	CbGbCtD
Pravastatin—CYP2C9—Cyclosporine—psoriasis	0.00565	0.0073	CbGbCtD
Pravastatin—CYP3A5—Dexamethasone—psoriasis	0.00555	0.00716	CbGbCtD
Pravastatin—ABCB1—Cyclosporine—psoriasis	0.00548	0.00708	CbGbCtD
Pravastatin—CYP2C8—Dexamethasone—psoriasis	0.00534	0.00689	CbGbCtD
Pravastatin—CYP2D6—Cyclosporine—psoriasis	0.00517	0.00667	CbGbCtD
Pravastatin—CYP3A4—Cholecalciferol—psoriasis	0.005	0.00646	CbGbCtD
Pravastatin—CYP3A4—Triamcinolone—psoriasis	0.00434	0.0056	CbGbCtD
Pravastatin—CYP3A4—Mycophenolate mofetil—psoriasis	0.00434	0.0056	CbGbCtD
Pravastatin—CYP2C9—Dexamethasone—psoriasis	0.00372	0.0048	CbGbCtD
Pravastatin—CYP3A4—Betamethasone—psoriasis	0.00372	0.0048	CbGbCtD
Pravastatin—CYP3A4—Prednisolone—psoriasis	0.00367	0.00474	CbGbCtD
Pravastatin—ABCB1—Dexamethasone—psoriasis	0.00361	0.00466	CbGbCtD
Pravastatin—CYP3A4—Hydrocortisone—psoriasis	0.00348	0.00449	CbGbCtD
Pravastatin—CYP3A4—Prednisone—psoriasis	0.00347	0.00448	CbGbCtD
Pravastatin—CYP2D6—Dexamethasone—psoriasis	0.0034	0.00439	CbGbCtD
Pravastatin—CYP3A4—Cyclosporine—psoriasis	0.00329	0.00424	CbGbCtD
Pravastatin—ABCB1—Methotrexate—psoriasis	0.0029	0.00375	CbGbCtD
Pravastatin—CYP3A4—Dexamethasone—psoriasis	0.00216	0.00279	CbGbCtD
Pravastatin—CYP2D6—CYP2E1 reactions—CYP2S1—psoriasis	0.000735	0.0323	CbGpPWpGaD
Pravastatin—CYP2C9—CYP2E1 reactions—CYP2S1—psoriasis	0.000729	0.032	CbGpPWpGaD
Pravastatin—CYP2D6—Miscellaneous substrates—CYP2S1—psoriasis	0.000686	0.0301	CbGpPWpGaD
Pravastatin—CYP3A5—Xenobiotics—CYP2S1—psoriasis	0.000641	0.0282	CbGpPWpGaD
Pravastatin—CYP2C8—Xenobiotics—CYP2S1—psoriasis	0.000555	0.0244	CbGpPWpGaD
Pravastatin—HMGCR—Activation of gene expression by SREBF (SREBP)—CARM1—psoriasis	0.000525	0.0231	CbGpPWpGaD
Pravastatin—CYP2D6—Xenobiotics—CYP2S1—psoriasis	0.000456	0.02	CbGpPWpGaD
Pravastatin—CYP2C9—Xenobiotics—CYP2S1—psoriasis	0.000452	0.0199	CbGpPWpGaD
Pravastatin—ABCB11—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000449	0.0197	CbGpPWpGaD
Pravastatin—HMGCR—Regulation of cholesterol biosynthesis by SREBP (SREBF)—CARM1—psoriasis	0.000419	0.0184	CbGpPWpGaD
Pravastatin—SLC16A1—The citric acid (TCA) cycle and respiratory electron transport—NDUFA5—psoriasis	0.00039	0.0171	CbGpPWpGaD
Pravastatin—ABCB1—Allograft Rejection—IL22—psoriasis	0.000388	0.0171	CbGpPWpGaD
Pravastatin—ABCC2—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000342	0.015	CbGpPWpGaD
Pravastatin—HMGCR—Statin Pathway—APOE—psoriasis	0.000325	0.0143	CbGpPWpGaD
Pravastatin—SLCO1B1—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000321	0.0141	CbGpPWpGaD
Pravastatin—CYP3A4—Xenobiotics—CYP2S1—psoriasis	0.000298	0.0131	CbGpPWpGaD
Pravastatin—HMGCR—Integrated Breast Cancer Pathway—ZMIZ1—psoriasis	0.000282	0.0124	CbGpPWpGaD
Pravastatin—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000266	0.0117	CbGpPWpGaD
Pravastatin—CYP3A5—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000263	0.0115	CbGpPWpGaD
Pravastatin—ABCB11—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000258	0.0113	CbGpPWpGaD
Pravastatin—ABCG2—Iron uptake and transport—CP—psoriasis	0.000248	0.0109	CbGpPWpGaD
Pravastatin—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—psoriasis	0.000242	0.0106	CbGpPWpGaD
Pravastatin—SLC16A1—Cell surface interactions at the vascular wall—ITGAL—psoriasis	0.000241	0.0106	CbGpPWpGaD
Pravastatin—SLC16A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—psoriasis	0.000237	0.0104	CbGpPWpGaD
Pravastatin—HMGCR—PPARA activates gene expression—CARM1—psoriasis	0.000234	0.0103	CbGpPWpGaD
Pravastatin—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000231	0.0101	CbGpPWpGaD
Pravastatin—HMGCR—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CARM1—psoriasis	0.000229	0.0101	CbGpPWpGaD
Pravastatin—CYP2C8—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000228	0.01	CbGpPWpGaD
Pravastatin—SLC16A1—Hemostasis—SERPINB8—psoriasis	0.000225	0.0099	CbGpPWpGaD
Pravastatin—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—psoriasis	0.000219	0.00963	CbGpPWpGaD
Pravastatin—CYP3A5—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000216	0.00948	CbGpPWpGaD
Pravastatin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000196	0.00862	CbGpPWpGaD
Pravastatin—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000189	0.00832	CbGpPWpGaD
Pravastatin—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000188	0.00824	CbGpPWpGaD
Pravastatin—CYP2C8—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000187	0.00821	CbGpPWpGaD
Pravastatin—CYP2D6—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000187	0.00821	CbGpPWpGaD
Pravastatin—CYP2C9—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000185	0.00814	CbGpPWpGaD
Pravastatin—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—psoriasis	0.000184	0.00809	CbGpPWpGaD
Pravastatin—ABCB11—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.00018	0.00791	CbGpPWpGaD
Pravastatin—ABCG2—HIF-1-alpha transcription factor network—CP—psoriasis	0.000176	0.00774	CbGpPWpGaD
Pravastatin—HMGCR—AMPK Signaling—LEP—psoriasis	0.000162	0.00713	CbGpPWpGaD
Pravastatin—ABCB1—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000161	0.00706	CbGpPWpGaD
Pravastatin—HMGCR—Fatty acid, triacylglycerol, and ketone body metabolism—CARM1—psoriasis	0.000158	0.00693	CbGpPWpGaD
Pravastatin—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—psoriasis	0.000154	0.00675	CbGpPWpGaD
Pravastatin—CYP2D6—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000153	0.00674	CbGpPWpGaD
Pravastatin—CYP2C9—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000152	0.00668	CbGpPWpGaD
Pravastatin—HMGCR—SREBP signalling—PPARG—psoriasis	0.000141	0.00621	CbGpPWpGaD
Pravastatin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000137	0.00601	CbGpPWpGaD
Pravastatin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000124	0.00544	CbGpPWpGaD
Pravastatin—CYP3A4—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000122	0.00537	CbGpPWpGaD
Pravastatin—SLCO2B1—SLC-mediated transmembrane transport—CP—psoriasis	0.000121	0.00532	CbGpPWpGaD
Pravastatin—CYP3A5—Biological oxidations—CYP2S1—psoriasis	0.000115	0.00504	CbGpPWpGaD
Pravastatin—CYP3A5—Metapathway biotransformation—CYP2S1—psoriasis	0.000113	0.00497	CbGpPWpGaD
Pravastatin—SLC22A11—SLC-mediated transmembrane transport—CP—psoriasis	0.00011	0.00482	CbGpPWpGaD
Pravastatin—SLC16A1—SLC-mediated transmembrane transport—CP—psoriasis	0.000108	0.00473	CbGpPWpGaD
Pravastatin—ABCC2—NRF2 pathway—TGFA—psoriasis	0.000102	0.0045	CbGpPWpGaD
Pravastatin—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.0001	0.00441	CbGpPWpGaD
Pravastatin—SLC22A7—SLC-mediated transmembrane transport—CP—psoriasis	9.96e-05	0.00438	CbGpPWpGaD
Pravastatin—CYP2C8—Biological oxidations—CYP2S1—psoriasis	9.93e-05	0.00436	CbGpPWpGaD
Pravastatin—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	9.9e-05	0.00435	CbGpPWpGaD
Pravastatin—CYP2C8—Metapathway biotransformation—CYP2S1—psoriasis	9.79e-05	0.0043	CbGpPWpGaD
Pravastatin—HMGCR—PPARA activates gene expression—PPARG—psoriasis	9.73e-05	0.00428	CbGpPWpGaD
Pravastatin—SLC22A7—Fluoropyrimidine Activity—TP53—psoriasis	9.65e-05	0.00424	CbGpPWpGaD
Pravastatin—ABCB1—HIF-1-alpha transcription factor network—CP—psoriasis	9.53e-05	0.00419	CbGpPWpGaD
Pravastatin—HMGCR—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—psoriasis	9.52e-05	0.00418	CbGpPWpGaD
Pravastatin—SLCO1B3—SLC-mediated transmembrane transport—CP—psoriasis	9.46e-05	0.00416	CbGpPWpGaD
Pravastatin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	9.23e-05	0.00405	CbGpPWpGaD
Pravastatin—Diarrhoea—Mycophenolic acid—psoriasis	8.95e-05	0.000458	CcSEcCtD
Pravastatin—Malaise—Betamethasone—psoriasis	8.88e-05	0.000454	CcSEcCtD
Pravastatin—Malaise—Dexamethasone—psoriasis	8.88e-05	0.000454	CcSEcCtD
Pravastatin—Oedema—Triamcinolone—psoriasis	8.85e-05	0.000453	CcSEcCtD
Pravastatin—Anaphylactic shock—Triamcinolone—psoriasis	8.85e-05	0.000453	CcSEcCtD
Pravastatin—Vertigo—Betamethasone—psoriasis	8.84e-05	0.000453	CcSEcCtD
Pravastatin—Vertigo—Dexamethasone—psoriasis	8.84e-05	0.000453	CcSEcCtD
Pravastatin—Pain—Mycophenolate mofetil—psoriasis	8.83e-05	0.000452	CcSEcCtD
Pravastatin—Constipation—Mycophenolate mofetil—psoriasis	8.83e-05	0.000452	CcSEcCtD
Pravastatin—Arrhythmia—Prednisone—psoriasis	8.8e-05	0.00045	CcSEcCtD
Pravastatin—Infection—Triamcinolone—psoriasis	8.8e-05	0.00045	CcSEcCtD
Pravastatin—Feeling abnormal—Cyclosporine—psoriasis	8.72e-05	0.000446	CcSEcCtD
Pravastatin—Insomnia—Prednisolone—psoriasis	8.71e-05	0.000446	CcSEcCtD
Pravastatin—Alopecia—Prednisone—psoriasis	8.7e-05	0.000446	CcSEcCtD
Pravastatin—Gastrointestinal pain—Cyclosporine—psoriasis	8.65e-05	0.000443	CcSEcCtD
Pravastatin—Dizziness—Mycophenolic acid—psoriasis	8.65e-05	0.000443	CcSEcCtD
Pravastatin—Paraesthesia—Prednisolone—psoriasis	8.64e-05	0.000443	CcSEcCtD
Pravastatin—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	8.62e-05	0.00379	CbGpPWpGaD
Pravastatin—Musculoskeletal discomfort—Hydrocortisone—psoriasis	8.57e-05	0.000439	CcSEcCtD
Pravastatin—Hyperhidrosis—Triamcinolone—psoriasis	8.56e-05	0.000438	CcSEcCtD
Pravastatin—Feeling abnormal—Mycophenolate mofetil—psoriasis	8.5e-05	0.000435	CcSEcCtD
Pravastatin—Insomnia—Hydrocortisone—psoriasis	8.5e-05	0.000435	CcSEcCtD
Pravastatin—Hypertension—Dexamethasone—psoriasis	8.5e-05	0.000435	CcSEcCtD
Pravastatin—Hypertension—Betamethasone—psoriasis	8.5e-05	0.000435	CcSEcCtD
Pravastatin—Paraesthesia—Hydrocortisone—psoriasis	8.44e-05	0.000432	CcSEcCtD
Pravastatin—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	8.44e-05	0.000432	CcSEcCtD
Pravastatin—Urticaria—Cyclosporine—psoriasis	8.4e-05	0.00043	CcSEcCtD
Pravastatin—Myalgia—Betamethasone—psoriasis	8.38e-05	0.000429	CcSEcCtD
Pravastatin—Myalgia—Dexamethasone—psoriasis	8.38e-05	0.000429	CcSEcCtD
Pravastatin—SLC22A8—SLC-mediated transmembrane transport—CP—psoriasis	8.37e-05	0.00368	CbGpPWpGaD
Pravastatin—Abdominal pain—Cyclosporine—psoriasis	8.36e-05	0.000428	CcSEcCtD
Pravastatin—Body temperature increased—Cyclosporine—psoriasis	8.36e-05	0.000428	CcSEcCtD
Pravastatin—Anxiety—Dexamethasone—psoriasis	8.35e-05	0.000428	CcSEcCtD
Pravastatin—Anxiety—Betamethasone—psoriasis	8.35e-05	0.000428	CcSEcCtD
Pravastatin—Vomiting—Mycophenolic acid—psoriasis	8.32e-05	0.000426	CcSEcCtD
Pravastatin—Discomfort—Dexamethasone—psoriasis	8.28e-05	0.000424	CcSEcCtD
Pravastatin—Discomfort—Betamethasone—psoriasis	8.28e-05	0.000424	CcSEcCtD
Pravastatin—Dyspepsia—Hydrocortisone—psoriasis	8.28e-05	0.000424	CcSEcCtD
Pravastatin—Rash—Mycophenolic acid—psoriasis	8.25e-05	0.000422	CcSEcCtD
Pravastatin—Dermatitis—Mycophenolic acid—psoriasis	8.24e-05	0.000422	CcSEcCtD
Pravastatin—Pain—Prednisolone—psoriasis	8.23e-05	0.000422	CcSEcCtD
Pravastatin—Hepatitis—Methotrexate—psoriasis	8.23e-05	0.000421	CcSEcCtD
Pravastatin—Urticaria—Mycophenolate mofetil—psoriasis	8.2e-05	0.00042	CcSEcCtD
Pravastatin—Headache—Mycophenolic acid—psoriasis	8.19e-05	0.000419	CcSEcCtD
Pravastatin—Decreased appetite—Hydrocortisone—psoriasis	8.17e-05	0.000418	CcSEcCtD
Pravastatin—Pharyngitis—Methotrexate—psoriasis	8.17e-05	0.000418	CcSEcCtD
Pravastatin—Abdominal pain—Mycophenolate mofetil—psoriasis	8.16e-05	0.000418	CcSEcCtD
Pravastatin—Body temperature increased—Mycophenolate mofetil—psoriasis	8.16e-05	0.000418	CcSEcCtD
Pravastatin—CYP2D6—Biological oxidations—CYP2S1—psoriasis	8.15e-05	0.00358	CbGpPWpGaD
Pravastatin—Fatigue—Hydrocortisone—psoriasis	8.11e-05	0.000415	CcSEcCtD
Pravastatin—CYP2C9—Biological oxidations—CYP2S1—psoriasis	8.08e-05	0.00355	CbGpPWpGaD
Pravastatin—Vision blurred—Prednisone—psoriasis	8.08e-05	0.000414	CcSEcCtD
Pravastatin—Musculoskeletal discomfort—Triamcinolone—psoriasis	8.07e-05	0.000413	CcSEcCtD
Pravastatin—Pain—Hydrocortisone—psoriasis	8.04e-05	0.000412	CcSEcCtD
Pravastatin—CYP2D6—Metapathway biotransformation—CYP2S1—psoriasis	8.04e-05	0.00353	CbGpPWpGaD
Pravastatin—ABCG2—HIF-1-alpha transcription factor network—LEP—psoriasis	8.03e-05	0.00353	CbGpPWpGaD
Pravastatin—Oedema—Dexamethasone—psoriasis	8.03e-05	0.000411	CcSEcCtD
Pravastatin—Anaphylactic shock—Betamethasone—psoriasis	8.03e-05	0.000411	CcSEcCtD
Pravastatin—Anaphylactic shock—Dexamethasone—psoriasis	8.03e-05	0.000411	CcSEcCtD
Pravastatin—Oedema—Betamethasone—psoriasis	8.03e-05	0.000411	CcSEcCtD
Pravastatin—Insomnia—Triamcinolone—psoriasis	8.01e-05	0.00041	CcSEcCtD
Pravastatin—Infection—Betamethasone—psoriasis	7.98e-05	0.000409	CcSEcCtD
Pravastatin—Infection—Dexamethasone—psoriasis	7.98e-05	0.000409	CcSEcCtD
Pravastatin—CYP2C9—Metapathway biotransformation—CYP2S1—psoriasis	7.97e-05	0.0035	CbGpPWpGaD
Pravastatin—Ill-defined disorder—Prednisone—psoriasis	7.95e-05	0.000407	CcSEcCtD
Pravastatin—Paraesthesia—Triamcinolone—psoriasis	7.95e-05	0.000407	CcSEcCtD
Pravastatin—Feeling abnormal—Prednisolone—psoriasis	7.93e-05	0.000406	CcSEcCtD
Pravastatin—Visual impairment—Methotrexate—psoriasis	7.93e-05	0.000406	CcSEcCtD
Pravastatin—Anaemia—Prednisone—psoriasis	7.92e-05	0.000406	CcSEcCtD
Pravastatin—CYP2D6—Melatonin metabolism and effects—APOE—psoriasis	7.9e-05	0.00347	CbGpPWpGaD
Pravastatin—Dyspnoea—Triamcinolone—psoriasis	7.89e-05	0.000404	CcSEcCtD
Pravastatin—Thrombocytopenia—Dexamethasone—psoriasis	7.87e-05	0.000403	CcSEcCtD
Pravastatin—Thrombocytopenia—Betamethasone—psoriasis	7.87e-05	0.000403	CcSEcCtD
Pravastatin—Angioedema—Prednisone—psoriasis	7.83e-05	0.000401	CcSEcCtD
Pravastatin—Hypersensitivity—Cyclosporine—psoriasis	7.79e-05	0.000399	CcSEcCtD
Pravastatin—Dyspepsia—Triamcinolone—psoriasis	7.79e-05	0.000399	CcSEcCtD
Pravastatin—Erythema multiforme—Methotrexate—psoriasis	7.78e-05	0.000398	CcSEcCtD
Pravastatin—Nausea—Mycophenolic acid—psoriasis	7.77e-05	0.000398	CcSEcCtD
Pravastatin—Hyperhidrosis—Betamethasone—psoriasis	7.77e-05	0.000398	CcSEcCtD
Pravastatin—Hyperhidrosis—Dexamethasone—psoriasis	7.77e-05	0.000398	CcSEcCtD
Pravastatin—Feeling abnormal—Hydrocortisone—psoriasis	7.75e-05	0.000397	CcSEcCtD
Pravastatin—Malaise—Prednisone—psoriasis	7.73e-05	0.000396	CcSEcCtD
Pravastatin—Vertigo—Prednisone—psoriasis	7.7e-05	0.000394	CcSEcCtD
Pravastatin—Gastrointestinal pain—Hydrocortisone—psoriasis	7.69e-05	0.000394	CcSEcCtD
Pravastatin—Tinnitus—Methotrexate—psoriasis	7.67e-05	0.000393	CcSEcCtD
Pravastatin—Anorexia—Betamethasone—psoriasis	7.66e-05	0.000392	CcSEcCtD
Pravastatin—Anorexia—Dexamethasone—psoriasis	7.66e-05	0.000392	CcSEcCtD
Pravastatin—Urticaria—Prednisolone—psoriasis	7.65e-05	0.000392	CcSEcCtD
Pravastatin—Cardiac disorder—Methotrexate—psoriasis	7.64e-05	0.000391	CcSEcCtD
Pravastatin—Fatigue—Triamcinolone—psoriasis	7.63e-05	0.000391	CcSEcCtD
Pravastatin—Hypersensitivity—Mycophenolate mofetil—psoriasis	7.6e-05	0.000389	CcSEcCtD
Pravastatin—Asthenia—Cyclosporine—psoriasis	7.59e-05	0.000389	CcSEcCtD
Pravastatin—Pain—Triamcinolone—psoriasis	7.57e-05	0.000388	CcSEcCtD
Pravastatin—ABCG2—HIF-1-alpha transcription factor network—NOS2—psoriasis	7.49e-05	0.00329	CbGpPWpGaD
Pravastatin—Pruritus—Cyclosporine—psoriasis	7.49e-05	0.000383	CcSEcCtD
Pravastatin—Urticaria—Hydrocortisone—psoriasis	7.47e-05	0.000382	CcSEcCtD
Pravastatin—Body temperature increased—Hydrocortisone—psoriasis	7.43e-05	0.000381	CcSEcCtD
Pravastatin—Abdominal pain—Hydrocortisone—psoriasis	7.43e-05	0.000381	CcSEcCtD
Pravastatin—SLCO1A2—SLC-mediated transmembrane transport—CP—psoriasis	7.43e-05	0.00327	CbGpPWpGaD
Pravastatin—Asthenia—Mycophenolate mofetil—psoriasis	7.4e-05	0.000379	CcSEcCtD
Pravastatin—Hypertension—Prednisone—psoriasis	7.4e-05	0.000379	CcSEcCtD
Pravastatin—Chills—Methotrexate—psoriasis	7.38e-05	0.000378	CcSEcCtD
Pravastatin—ABCG2—HIF-2-alpha transcription factor network—VEGFA—psoriasis	7.37e-05	0.00324	CbGpPWpGaD
Pravastatin—ABCB1—Allograft Rejection—HLA-C—psoriasis	7.35e-05	0.00323	CbGpPWpGaD
Pravastatin—Musculoskeletal discomfort—Dexamethasone—psoriasis	7.32e-05	0.000375	CcSEcCtD
Pravastatin—Musculoskeletal discomfort—Betamethasone—psoriasis	7.32e-05	0.000375	CcSEcCtD
Pravastatin—ABCB1—Allograft Rejection—IL13—psoriasis	7.31e-05	0.00321	CbGpPWpGaD
Pravastatin—Pruritus—Mycophenolate mofetil—psoriasis	7.3e-05	0.000374	CcSEcCtD
Pravastatin—Myalgia—Prednisone—psoriasis	7.3e-05	0.000374	CcSEcCtD
Pravastatin—Arthralgia—Prednisone—psoriasis	7.3e-05	0.000374	CcSEcCtD
Pravastatin—Feeling abnormal—Triamcinolone—psoriasis	7.3e-05	0.000374	CcSEcCtD
Pravastatin—Anxiety—Prednisone—psoriasis	7.27e-05	0.000372	CcSEcCtD
Pravastatin—Alopecia—Methotrexate—psoriasis	7.27e-05	0.000372	CcSEcCtD
Pravastatin—Insomnia—Dexamethasone—psoriasis	7.27e-05	0.000372	CcSEcCtD
Pravastatin—Insomnia—Betamethasone—psoriasis	7.27e-05	0.000372	CcSEcCtD
Pravastatin—Diarrhoea—Cyclosporine—psoriasis	7.24e-05	0.000371	CcSEcCtD
Pravastatin—Paraesthesia—Betamethasone—psoriasis	7.21e-05	0.000369	CcSEcCtD
Pravastatin—Paraesthesia—Dexamethasone—psoriasis	7.21e-05	0.000369	CcSEcCtD
Pravastatin—Discomfort—Prednisone—psoriasis	7.21e-05	0.000369	CcSEcCtD
Pravastatin—Hypersensitivity—Prednisolone—psoriasis	7.09e-05	0.000363	CcSEcCtD
Pravastatin—Dyspepsia—Betamethasone—psoriasis	7.07e-05	0.000362	CcSEcCtD
Pravastatin—Dyspepsia—Dexamethasone—psoriasis	7.07e-05	0.000362	CcSEcCtD
Pravastatin—Diarrhoea—Mycophenolate mofetil—psoriasis	7.06e-05	0.000362	CcSEcCtD
Pravastatin—Urticaria—Triamcinolone—psoriasis	7.03e-05	0.00036	CcSEcCtD
Pravastatin—Dysgeusia—Methotrexate—psoriasis	7.02e-05	0.000359	CcSEcCtD
Pravastatin—Body temperature increased—Triamcinolone—psoriasis	7e-05	0.000358	CcSEcCtD
Pravastatin—Dizziness—Cyclosporine—psoriasis	7e-05	0.000358	CcSEcCtD
Pravastatin—Oedema—Prednisone—psoriasis	7e-05	0.000358	CcSEcCtD
Pravastatin—Anaphylactic shock—Prednisone—psoriasis	7e-05	0.000358	CcSEcCtD
Pravastatin—SLC22A6—SLC-mediated transmembrane transport—CP—psoriasis	6.99e-05	0.00307	CbGpPWpGaD
Pravastatin—Decreased appetite—Betamethasone—psoriasis	6.98e-05	0.000358	CcSEcCtD
Pravastatin—Decreased appetite—Dexamethasone—psoriasis	6.98e-05	0.000358	CcSEcCtD
Pravastatin—Infection—Prednisone—psoriasis	6.95e-05	0.000356	CcSEcCtD
Pravastatin—Hypersensitivity—Hydrocortisone—psoriasis	6.93e-05	0.000355	CcSEcCtD
Pravastatin—Fatigue—Betamethasone—psoriasis	6.93e-05	0.000355	CcSEcCtD
Pravastatin—Fatigue—Dexamethasone—psoriasis	6.93e-05	0.000355	CcSEcCtD
Pravastatin—Pain—Betamethasone—psoriasis	6.87e-05	0.000352	CcSEcCtD
Pravastatin—Pain—Dexamethasone—psoriasis	6.87e-05	0.000352	CcSEcCtD
Pravastatin—Dizziness—Mycophenolate mofetil—psoriasis	6.82e-05	0.000349	CcSEcCtD
Pravastatin—Hyperhidrosis—Prednisone—psoriasis	6.76e-05	0.000346	CcSEcCtD
Pravastatin—Vision blurred—Methotrexate—psoriasis	6.75e-05	0.000346	CcSEcCtD
Pravastatin—Asthenia—Hydrocortisone—psoriasis	6.75e-05	0.000345	CcSEcCtD
Pravastatin—HMGCR—Metabolism—NDUFA5—psoriasis	6.73e-05	0.00296	CbGpPWpGaD
Pravastatin—Vomiting—Cyclosporine—psoriasis	6.73e-05	0.000344	CcSEcCtD
Pravastatin—ABCB1—Allograft Rejection—IL17A—psoriasis	6.73e-05	0.00296	CbGpPWpGaD
Pravastatin—Rash—Cyclosporine—psoriasis	6.67e-05	0.000342	CcSEcCtD
Pravastatin—Anorexia—Prednisone—psoriasis	6.67e-05	0.000341	CcSEcCtD
Pravastatin—Dermatitis—Cyclosporine—psoriasis	6.66e-05	0.000341	CcSEcCtD
Pravastatin—Pruritus—Hydrocortisone—psoriasis	6.65e-05	0.000341	CcSEcCtD
Pravastatin—Ill-defined disorder—Methotrexate—psoriasis	6.65e-05	0.00034	CcSEcCtD
Pravastatin—Headache—Cyclosporine—psoriasis	6.63e-05	0.000339	CcSEcCtD
Pravastatin—Anaemia—Methotrexate—psoriasis	6.62e-05	0.000339	CcSEcCtD
Pravastatin—Feeling abnormal—Dexamethasone—psoriasis	6.62e-05	0.000339	CcSEcCtD
Pravastatin—Feeling abnormal—Betamethasone—psoriasis	6.62e-05	0.000339	CcSEcCtD
Pravastatin—HMGCR—AMPK Signaling—TP53—psoriasis	6.62e-05	0.00291	CbGpPWpGaD
Pravastatin—Gastrointestinal pain—Dexamethasone—psoriasis	6.57e-05	0.000336	CcSEcCtD
Pravastatin—Gastrointestinal pain—Betamethasone—psoriasis	6.57e-05	0.000336	CcSEcCtD
Pravastatin—Vomiting—Mycophenolate mofetil—psoriasis	6.56e-05	0.000336	CcSEcCtD
Pravastatin—HMGCR—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—psoriasis	6.56e-05	0.00288	CbGpPWpGaD
Pravastatin—SLC16A1—Hemostasis—ITGAL—psoriasis	6.54e-05	0.00287	CbGpPWpGaD
Pravastatin—Hypersensitivity—Triamcinolone—psoriasis	6.52e-05	0.000334	CcSEcCtD
Pravastatin—Rash—Mycophenolate mofetil—psoriasis	6.51e-05	0.000333	CcSEcCtD
Pravastatin—Dermatitis—Mycophenolate mofetil—psoriasis	6.5e-05	0.000333	CcSEcCtD
Pravastatin—Headache—Mycophenolate mofetil—psoriasis	6.47e-05	0.000331	CcSEcCtD
Pravastatin—Malaise—Methotrexate—psoriasis	6.46e-05	0.000331	CcSEcCtD
Pravastatin—Vertigo—Methotrexate—psoriasis	6.44e-05	0.00033	CcSEcCtD
Pravastatin—Diarrhoea—Hydrocortisone—psoriasis	6.43e-05	0.000329	CcSEcCtD
Pravastatin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	6.43e-05	0.00283	CbGpPWpGaD
Pravastatin—Leukopenia—Methotrexate—psoriasis	6.41e-05	0.000328	CcSEcCtD
Pravastatin—Urticaria—Betamethasone—psoriasis	6.38e-05	0.000327	CcSEcCtD
Pravastatin—Urticaria—Dexamethasone—psoriasis	6.38e-05	0.000327	CcSEcCtD
Pravastatin—Musculoskeletal discomfort—Prednisone—psoriasis	6.37e-05	0.000326	CcSEcCtD
Pravastatin—Dizziness—Prednisolone—psoriasis	6.37e-05	0.000326	CcSEcCtD
Pravastatin—SLCO1B1—SLC-mediated transmembrane transport—CP—psoriasis	6.36e-05	0.00279	CbGpPWpGaD
Pravastatin—Asthenia—Triamcinolone—psoriasis	6.35e-05	0.000325	CcSEcCtD
Pravastatin—Abdominal pain—Dexamethasone—psoriasis	6.35e-05	0.000325	CcSEcCtD
Pravastatin—Abdominal pain—Betamethasone—psoriasis	6.35e-05	0.000325	CcSEcCtD
Pravastatin—Body temperature increased—Dexamethasone—psoriasis	6.35e-05	0.000325	CcSEcCtD
Pravastatin—Body temperature increased—Betamethasone—psoriasis	6.35e-05	0.000325	CcSEcCtD
Pravastatin—Insomnia—Prednisone—psoriasis	6.33e-05	0.000324	CcSEcCtD
Pravastatin—Nausea—Cyclosporine—psoriasis	6.28e-05	0.000322	CcSEcCtD
Pravastatin—Paraesthesia—Prednisone—psoriasis	6.28e-05	0.000322	CcSEcCtD
Pravastatin—HMGCR—Metabolism of lipids and lipoproteins—CARM1—psoriasis	6.28e-05	0.00276	CbGpPWpGaD
Pravastatin—Pruritus—Triamcinolone—psoriasis	6.26e-05	0.000321	CcSEcCtD
Pravastatin—ABCB1—Allograft Rejection—IL12B—psoriasis	6.25e-05	0.00275	CbGpPWpGaD
Pravastatin—Cough—Methotrexate—psoriasis	6.25e-05	0.00032	CcSEcCtD
Pravastatin—Dizziness—Hydrocortisone—psoriasis	6.22e-05	0.000318	CcSEcCtD
Pravastatin—Dyspepsia—Prednisone—psoriasis	6.16e-05	0.000315	CcSEcCtD
Pravastatin—SLCO2B1—Transmembrane transport of small molecules—CP—psoriasis	6.16e-05	0.0027	CbGpPWpGaD
Pravastatin—Nausea—Mycophenolate mofetil—psoriasis	6.13e-05	0.000314	CcSEcCtD
Pravastatin—ABCB1—Allograft Rejection—HLA-E—psoriasis	6.1e-05	0.00268	CbGpPWpGaD
Pravastatin—Myalgia—Methotrexate—psoriasis	6.1e-05	0.000312	CcSEcCtD
Pravastatin—Arthralgia—Methotrexate—psoriasis	6.1e-05	0.000312	CcSEcCtD
Pravastatin—Chest pain—Methotrexate—psoriasis	6.1e-05	0.000312	CcSEcCtD
Pravastatin—Decreased appetite—Prednisone—psoriasis	6.08e-05	0.000311	CcSEcCtD
Pravastatin—Rash—Prednisolone—psoriasis	6.07e-05	0.000311	CcSEcCtD
Pravastatin—Dermatitis—Prednisolone—psoriasis	6.06e-05	0.000311	CcSEcCtD
Pravastatin—Fatigue—Prednisone—psoriasis	6.03e-05	0.000309	CcSEcCtD
Pravastatin—Headache—Prednisolone—psoriasis	6.03e-05	0.000309	CcSEcCtD
Pravastatin—Discomfort—Methotrexate—psoriasis	6.03e-05	0.000309	CcSEcCtD
Pravastatin—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	6.01e-05	0.00264	CbGpPWpGaD
Pravastatin—Constipation—Prednisone—psoriasis	5.98e-05	0.000306	CcSEcCtD
Pravastatin—Vomiting—Hydrocortisone—psoriasis	5.98e-05	0.000306	CcSEcCtD
Pravastatin—Rash—Hydrocortisone—psoriasis	5.93e-05	0.000304	CcSEcCtD
Pravastatin—Dermatitis—Hydrocortisone—psoriasis	5.92e-05	0.000303	CcSEcCtD
Pravastatin—Confusional state—Methotrexate—psoriasis	5.9e-05	0.000302	CcSEcCtD
Pravastatin—Headache—Hydrocortisone—psoriasis	5.89e-05	0.000302	CcSEcCtD
Pravastatin—SLC16A1—Metabolism—NDUFA5—psoriasis	5.88e-05	0.00259	CbGpPWpGaD
Pravastatin—SLCO2B1—Transmembrane transport of small molecules—CARM1—psoriasis	5.87e-05	0.00258	CbGpPWpGaD
Pravastatin—Dizziness—Triamcinolone—psoriasis	5.85e-05	0.0003	CcSEcCtD
Pravastatin—Anaphylactic shock—Methotrexate—psoriasis	5.85e-05	0.000299	CcSEcCtD
Pravastatin—Infection—Methotrexate—psoriasis	5.81e-05	0.000297	CcSEcCtD
Pravastatin—Feeling abnormal—Prednisone—psoriasis	5.77e-05	0.000295	CcSEcCtD
Pravastatin—Asthenia—Betamethasone—psoriasis	5.76e-05	0.000295	CcSEcCtD
Pravastatin—Asthenia—Dexamethasone—psoriasis	5.76e-05	0.000295	CcSEcCtD
Pravastatin—HMGCR—Metabolism—CYP2S1—psoriasis	5.72e-05	0.00252	CbGpPWpGaD
Pravastatin—Thrombocytopenia—Methotrexate—psoriasis	5.72e-05	0.000293	CcSEcCtD
Pravastatin—Gastrointestinal pain—Prednisone—psoriasis	5.72e-05	0.000293	CcSEcCtD
Pravastatin—Nausea—Prednisolone—psoriasis	5.72e-05	0.000293	CcSEcCtD
Pravastatin—ABCG2—Fluoropyrimidine Activity—TP53—psoriasis	5.7e-05	0.00251	CbGpPWpGaD
Pravastatin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	5.68e-05	0.0025	CbGpPWpGaD
Pravastatin—Pruritus—Betamethasone—psoriasis	5.68e-05	0.000291	CcSEcCtD
Pravastatin—Pruritus—Dexamethasone—psoriasis	5.68e-05	0.000291	CcSEcCtD
Pravastatin—Hyperhidrosis—Methotrexate—psoriasis	5.65e-05	0.000289	CcSEcCtD
Pravastatin—Vomiting—Triamcinolone—psoriasis	5.63e-05	0.000288	CcSEcCtD
Pravastatin—Nausea—Hydrocortisone—psoriasis	5.59e-05	0.000286	CcSEcCtD
Pravastatin—Rash—Triamcinolone—psoriasis	5.58e-05	0.000286	CcSEcCtD
Pravastatin—Dermatitis—Triamcinolone—psoriasis	5.58e-05	0.000286	CcSEcCtD
Pravastatin—SLC22A11—Transmembrane transport of small molecules—CP—psoriasis	5.58e-05	0.00245	CbGpPWpGaD
Pravastatin—Anorexia—Methotrexate—psoriasis	5.57e-05	0.000285	CcSEcCtD
Pravastatin—Urticaria—Prednisone—psoriasis	5.56e-05	0.000285	CcSEcCtD
Pravastatin—Headache—Triamcinolone—psoriasis	5.55e-05	0.000284	CcSEcCtD
Pravastatin—Body temperature increased—Prednisone—psoriasis	5.53e-05	0.000283	CcSEcCtD
Pravastatin—Abdominal pain—Prednisone—psoriasis	5.53e-05	0.000283	CcSEcCtD
Pravastatin—Diarrhoea—Betamethasone—psoriasis	5.5e-05	0.000281	CcSEcCtD
Pravastatin—Diarrhoea—Dexamethasone—psoriasis	5.5e-05	0.000281	CcSEcCtD
Pravastatin—SLC16A1—Transmembrane transport of small molecules—CP—psoriasis	5.47e-05	0.0024	CbGpPWpGaD
Pravastatin—HMGCR—Integrated Breast Cancer Pathway—JUN—psoriasis	5.36e-05	0.00235	CbGpPWpGaD
Pravastatin—CYP3A4—Biological oxidations—CYP2S1—psoriasis	5.33e-05	0.00234	CbGpPWpGaD
Pravastatin—Musculoskeletal discomfort—Methotrexate—psoriasis	5.33e-05	0.000273	CcSEcCtD
Pravastatin—SLC22A11—Transmembrane transport of small molecules—CARM1—psoriasis	5.32e-05	0.00234	CbGpPWpGaD
Pravastatin—Dizziness—Dexamethasone—psoriasis	5.31e-05	0.000272	CcSEcCtD
Pravastatin—Dizziness—Betamethasone—psoriasis	5.31e-05	0.000272	CcSEcCtD
Pravastatin—Insomnia—Methotrexate—psoriasis	5.29e-05	0.000271	CcSEcCtD
Pravastatin—Nausea—Triamcinolone—psoriasis	5.26e-05	0.000269	CcSEcCtD
Pravastatin—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	5.26e-05	0.00231	CbGpPWpGaD
Pravastatin—Paraesthesia—Methotrexate—psoriasis	5.25e-05	0.000269	CcSEcCtD
Pravastatin—SLC16A1—Transmembrane transport of small molecules—CARM1—psoriasis	5.22e-05	0.00229	CbGpPWpGaD
Pravastatin—Dyspnoea—Methotrexate—psoriasis	5.21e-05	0.000267	CcSEcCtD
Pravastatin—SLCO1B3—Metabolism—NDUFA5—psoriasis	5.17e-05	0.00227	CbGpPWpGaD
Pravastatin—HMGCR—Integrated Breast Cancer Pathway—NFKB1—psoriasis	5.16e-05	0.00227	CbGpPWpGaD
Pravastatin—Hypersensitivity—Prednisone—psoriasis	5.15e-05	0.000264	CcSEcCtD
Pravastatin—Dyspepsia—Methotrexate—psoriasis	5.15e-05	0.000264	CcSEcCtD
Pravastatin—Vomiting—Betamethasone—psoriasis	5.11e-05	0.000262	CcSEcCtD
Pravastatin—Vomiting—Dexamethasone—psoriasis	5.11e-05	0.000262	CcSEcCtD
Pravastatin—Decreased appetite—Methotrexate—psoriasis	5.08e-05	0.00026	CcSEcCtD
Pravastatin—Rash—Betamethasone—psoriasis	5.07e-05	0.000259	CcSEcCtD
Pravastatin—Rash—Dexamethasone—psoriasis	5.07e-05	0.000259	CcSEcCtD
Pravastatin—Dermatitis—Betamethasone—psoriasis	5.06e-05	0.000259	CcSEcCtD
Pravastatin—Dermatitis—Dexamethasone—psoriasis	5.06e-05	0.000259	CcSEcCtD
Pravastatin—SLC22A7—Transmembrane transport of small molecules—CP—psoriasis	5.06e-05	0.00222	CbGpPWpGaD
Pravastatin—ABCB1—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	5.05e-05	0.00222	CbGpPWpGaD
Pravastatin—Fatigue—Methotrexate—psoriasis	5.04e-05	0.000258	CcSEcCtD
Pravastatin—Headache—Betamethasone—psoriasis	5.03e-05	0.000258	CcSEcCtD
Pravastatin—Headache—Dexamethasone—psoriasis	5.03e-05	0.000258	CcSEcCtD
Pravastatin—Asthenia—Prednisone—psoriasis	5.02e-05	0.000257	CcSEcCtD
Pravastatin—SLC16A1—Metabolism—CYP2S1—psoriasis	5e-05	0.0022	CbGpPWpGaD
Pravastatin—Pain—Methotrexate—psoriasis	5e-05	0.000256	CcSEcCtD
Pravastatin—ABCG2—HIF-1-alpha transcription factor network—JUN—psoriasis	4.96e-05	0.00218	CbGpPWpGaD
Pravastatin—Pruritus—Prednisone—psoriasis	4.95e-05	0.000253	CcSEcCtD
Pravastatin—ABCB11—Metabolism—NDUFA5—psoriasis	4.87e-05	0.00214	CbGpPWpGaD
Pravastatin—SLC22A7—Transmembrane transport of small molecules—CARM1—psoriasis	4.83e-05	0.00212	CbGpPWpGaD
Pravastatin—SLCO1B3—Metabolism of lipids and lipoproteins—CARM1—psoriasis	4.82e-05	0.00212	CbGpPWpGaD
Pravastatin—Feeling abnormal—Methotrexate—psoriasis	4.82e-05	0.000247	CcSEcCtD
Pravastatin—SLCO1B3—Transmembrane transport of small molecules—CP—psoriasis	4.81e-05	0.00211	CbGpPWpGaD
Pravastatin—Diarrhoea—Prednisone—psoriasis	4.79e-05	0.000245	CcSEcCtD
Pravastatin—Gastrointestinal pain—Methotrexate—psoriasis	4.78e-05	0.000245	CcSEcCtD
Pravastatin—Nausea—Dexamethasone—psoriasis	4.77e-05	0.000244	CcSEcCtD
Pravastatin—Nausea—Betamethasone—psoriasis	4.77e-05	0.000244	CcSEcCtD
Pravastatin—CYP2D6—Melatonin metabolism and effects—NFKB1—psoriasis	4.7e-05	0.00206	CbGpPWpGaD
Pravastatin—HMGCR—Integrated Breast Cancer Pathway—VEGFA—psoriasis	4.68e-05	0.00206	CbGpPWpGaD
Pravastatin—Urticaria—Methotrexate—psoriasis	4.64e-05	0.000238	CcSEcCtD
Pravastatin—Dizziness—Prednisone—psoriasis	4.63e-05	0.000237	CcSEcCtD
Pravastatin—Abdominal pain—Methotrexate—psoriasis	4.62e-05	0.000237	CcSEcCtD
Pravastatin—Body temperature increased—Methotrexate—psoriasis	4.62e-05	0.000237	CcSEcCtD
Pravastatin—CYP3A4—Tryptophan metabolism—CAT—psoriasis	4.6e-05	0.00202	CbGpPWpGaD
Pravastatin—SLCO1B3—Transmembrane transport of small molecules—CARM1—psoriasis	4.59e-05	0.00201	CbGpPWpGaD
Pravastatin—ABCB1—Allograft Rejection—IL10—psoriasis	4.57e-05	0.00201	CbGpPWpGaD
Pravastatin—ABCB11—Metabolism of lipids and lipoproteins—CARM1—psoriasis	4.54e-05	0.00199	CbGpPWpGaD
Pravastatin—Vomiting—Prednisone—psoriasis	4.45e-05	0.000228	CcSEcCtD
Pravastatin—ABCB1—Allograft Rejection—IL4—psoriasis	4.45e-05	0.00195	CbGpPWpGaD
Pravastatin—Rash—Prednisone—psoriasis	4.41e-05	0.000226	CcSEcCtD
Pravastatin—Dermatitis—Prednisone—psoriasis	4.41e-05	0.000226	CcSEcCtD
Pravastatin—SLCO1B3—Metabolism—CYP2S1—psoriasis	4.4e-05	0.00193	CbGpPWpGaD
Pravastatin—Headache—Prednisone—psoriasis	4.38e-05	0.000224	CcSEcCtD
Pravastatin—ABCB1—Allograft Rejection—HLA-B—psoriasis	4.35e-05	0.00191	CbGpPWpGaD
Pravastatin—ABCB1—HIF-1-alpha transcription factor network—LEP—psoriasis	4.34e-05	0.00191	CbGpPWpGaD
Pravastatin—ABCG2—HIF-1-alpha transcription factor network—VEGFA—psoriasis	4.34e-05	0.00191	CbGpPWpGaD
Pravastatin—Hypersensitivity—Methotrexate—psoriasis	4.31e-05	0.000221	CcSEcCtD
Pravastatin—SLC22A8—Transmembrane transport of small molecules—CP—psoriasis	4.25e-05	0.00187	CbGpPWpGaD
Pravastatin—Asthenia—Methotrexate—psoriasis	4.19e-05	0.000215	CcSEcCtD
Pravastatin—Nausea—Prednisone—psoriasis	4.16e-05	0.000213	CcSEcCtD
Pravastatin—ABCB11—Metabolism—CYP2S1—psoriasis	4.14e-05	0.00182	CbGpPWpGaD
Pravastatin—Pruritus—Methotrexate—psoriasis	4.14e-05	0.000212	CcSEcCtD
Pravastatin—SLCO1A2—Metabolism—NDUFA5—psoriasis	4.06e-05	0.00179	CbGpPWpGaD
Pravastatin—SLC22A8—Transmembrane transport of small molecules—CARM1—psoriasis	4.06e-05	0.00178	CbGpPWpGaD
Pravastatin—ABCB1—HIF-1-alpha transcription factor network—NOS2—psoriasis	4.05e-05	0.00178	CbGpPWpGaD
Pravastatin—ABCB1—Allograft Rejection—HLA-A—psoriasis	4.03e-05	0.00177	CbGpPWpGaD
Pravastatin—Diarrhoea—Methotrexate—psoriasis	4e-05	0.000205	CcSEcCtD
Pravastatin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	3.96e-05	0.00174	CbGpPWpGaD
Pravastatin—Dizziness—Methotrexate—psoriasis	3.87e-05	0.000198	CcSEcCtD
Pravastatin—SLCO1A2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	3.79e-05	0.00166	CbGpPWpGaD
Pravastatin—SLCO1A2—Transmembrane transport of small molecules—CP—psoriasis	3.78e-05	0.00166	CbGpPWpGaD
Pravastatin—Vomiting—Methotrexate—psoriasis	3.72e-05	0.00019	CcSEcCtD
Pravastatin—Rash—Methotrexate—psoriasis	3.69e-05	0.000189	CcSEcCtD
Pravastatin—Dermatitis—Methotrexate—psoriasis	3.68e-05	0.000189	CcSEcCtD
Pravastatin—ABCB1—Allograft Rejection—HLA-DRB1—psoriasis	3.68e-05	0.00162	CbGpPWpGaD
Pravastatin—Headache—Methotrexate—psoriasis	3.66e-05	0.000188	CcSEcCtD
Pravastatin—SLCO1A2—Transmembrane transport of small molecules—CARM1—psoriasis	3.6e-05	0.00158	CbGpPWpGaD
Pravastatin—SLC22A6—Transmembrane transport of small molecules—CP—psoriasis	3.55e-05	0.00156	CbGpPWpGaD
Pravastatin—HMGCR—Integrated Breast Cancer Pathway—TP53—psoriasis	3.54e-05	0.00155	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism—NDUFA5—psoriasis	3.47e-05	0.00153	CbGpPWpGaD
Pravastatin—Nausea—Methotrexate—psoriasis	3.47e-05	0.000178	CcSEcCtD
Pravastatin—SLCO1A2—Metabolism—CYP2S1—psoriasis	3.46e-05	0.00152	CbGpPWpGaD
Pravastatin—ABCC2—Transmembrane transport of small molecules—CP—psoriasis	3.44e-05	0.00151	CbGpPWpGaD
Pravastatin—SLC22A6—Transmembrane transport of small molecules—CARM1—psoriasis	3.39e-05	0.00149	CbGpPWpGaD
Pravastatin—ABCC2—Transmembrane transport of small molecules—CARM1—psoriasis	3.28e-05	0.00144	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	3.24e-05	0.00142	CbGpPWpGaD
Pravastatin—SLCO1B1—Transmembrane transport of small molecules—CP—psoriasis	3.23e-05	0.00142	CbGpPWpGaD
Pravastatin—ABCG2—Metabolism—NDUFA5—psoriasis	3.22e-05	0.00141	CbGpPWpGaD
Pravastatin—SLCO1B1—Transmembrane transport of small molecules—CARM1—psoriasis	3.08e-05	0.00135	CbGpPWpGaD
Pravastatin—HMGCR—Metabolism of lipids and lipoproteins—APOE—psoriasis	3e-05	0.00132	CbGpPWpGaD
Pravastatin—ABCG2—Transmembrane transport of small molecules—CP—psoriasis	2.99e-05	0.00131	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism—CYP2S1—psoriasis	2.95e-05	0.0013	CbGpPWpGaD
Pravastatin—ABCG2—Transmembrane transport of small molecules—CARM1—psoriasis	2.85e-05	0.00125	CbGpPWpGaD
Pravastatin—HMGCR—Metabolism—CARM1—psoriasis	2.8e-05	0.00123	CbGpPWpGaD
Pravastatin—ABCG2—Metabolism—CYP2S1—psoriasis	2.74e-05	0.0012	CbGpPWpGaD
Pravastatin—ABCB1—Allograft Rejection—IFNG—psoriasis	2.69e-05	0.00118	CbGpPWpGaD
Pravastatin—SLC16A1—Hemostasis—NOS2—psoriasis	2.68e-05	0.00118	CbGpPWpGaD
Pravastatin—ABCB1—HIF-1-alpha transcription factor network—JUN—psoriasis	2.68e-05	0.00118	CbGpPWpGaD
Pravastatin—HMGCR—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.61e-05	0.00115	CbGpPWpGaD
Pravastatin—ABCB1—Allograft Rejection—CXCL8—psoriasis	2.5e-05	0.0011	CbGpPWpGaD
Pravastatin—SLC16A1—Metabolism—CARM1—psoriasis	2.44e-05	0.00107	CbGpPWpGaD
Pravastatin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—psoriasis	2.34e-05	0.00103	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—NDUFA5—psoriasis	2.31e-05	0.00101	CbGpPWpGaD
Pravastatin—SLCO1B3—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.3e-05	0.00101	CbGpPWpGaD
Pravastatin—ABCB11—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.17e-05	0.000953	CbGpPWpGaD
Pravastatin—SLCO1B3—Metabolism—CARM1—psoriasis	2.15e-05	0.000944	CbGpPWpGaD
Pravastatin—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	2.06e-05	0.000905	CbGpPWpGaD
Pravastatin—ABCB1—Allograft Rejection—VEGFA—psoriasis	2.03e-05	0.000892	CbGpPWpGaD
Pravastatin—ABCB11—Metabolism—CARM1—psoriasis	2.02e-05	0.000888	CbGpPWpGaD
Pravastatin—SLCO1B3—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.01e-05	0.000882	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—NDUFA5—psoriasis	2e-05	0.000877	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—CYP2S1—psoriasis	1.96e-05	0.000861	CbGpPWpGaD
Pravastatin—ABCB11—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.89e-05	0.00083	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.86e-05	0.000818	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.81e-05	0.000796	CbGpPWpGaD
Pravastatin—ABCB1—Allograft Rejection—TNF—psoriasis	1.74e-05	0.000765	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—NDUFA5—psoriasis	1.74e-05	0.000764	CbGpPWpGaD
Pravastatin—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	1.73e-05	0.00076	CbGpPWpGaD
Pravastatin—HMGCR—Metabolism—CAT—psoriasis	1.72e-05	0.000756	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—CYP2S1—psoriasis	1.7e-05	0.000746	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism—CARM1—psoriasis	1.69e-05	0.000741	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—NDUFA5—psoriasis	1.64e-05	0.00072	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—NDUFA5—psoriasis	1.63e-05	0.000714	CbGpPWpGaD
Pravastatin—ABCB1—Transmembrane transport of small molecules—CP—psoriasis	1.62e-05	0.00071	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.58e-05	0.000693	CbGpPWpGaD
Pravastatin—SLC16A1—Hemostasis—VEGFA—psoriasis	1.55e-05	0.000683	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.55e-05	0.00068	CbGpPWpGaD
Pravastatin—ABCB1—Transmembrane transport of small molecules—CARM1—psoriasis	1.54e-05	0.000678	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.52e-05	0.000666	CbGpPWpGaD
Pravastatin—SLC16A1—Metabolism—CAT—psoriasis	1.5e-05	0.00066	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—CYP2S1—psoriasis	1.48e-05	0.00065	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism—CARM1—psoriasis	1.44e-05	0.000634	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—CYP2S1—psoriasis	1.39e-05	0.000612	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—CYP2S1—psoriasis	1.38e-05	0.000607	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.35e-05	0.000593	CbGpPWpGaD
Pravastatin—HMGCR—Metabolism—APOE—psoriasis	1.34e-05	0.000587	CbGpPWpGaD
Pravastatin—ABCG2—Metabolism—CARM1—psoriasis	1.34e-05	0.000587	CbGpPWpGaD
Pravastatin—SLCO1B3—Metabolism—CAT—psoriasis	1.32e-05	0.00058	CbGpPWpGaD
Pravastatin—ABCB11—Metabolism—CAT—psoriasis	1.24e-05	0.000546	CbGpPWpGaD
Pravastatin—SLC16A1—Hemostasis—TP53—psoriasis	1.17e-05	0.000516	CbGpPWpGaD
Pravastatin—SLC16A1—Metabolism—APOE—psoriasis	1.17e-05	0.000513	CbGpPWpGaD
Pravastatin—HMGCR—Metabolism—PPARG—psoriasis	1.16e-05	0.000511	CbGpPWpGaD
Pravastatin—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	1.15e-05	0.000504	CbGpPWpGaD
Pravastatin—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	1.1e-05	0.000485	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—NDUFA5—psoriasis	1.07e-05	0.000471	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism—CAT—psoriasis	1.04e-05	0.000456	CbGpPWpGaD
Pravastatin—SLCO1B3—Metabolism—APOE—psoriasis	1.03e-05	0.000451	CbGpPWpGaD
Pravastatin—SLC16A1—Metabolism—PPARG—psoriasis	1.02e-05	0.000447	CbGpPWpGaD
Pravastatin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	1e-05	0.00044	CbGpPWpGaD
Pravastatin—ABCB11—Metabolism—APOE—psoriasis	9.66e-06	0.000424	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—CARM1—psoriasis	9.57e-06	0.000421	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—CYP2S1—psoriasis	9.11e-06	0.0004	CbGpPWpGaD
Pravastatin—SLCO1B3—Metabolism—PPARG—psoriasis	8.94e-06	0.000393	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism of lipids and lipoproteins—APOE—psoriasis	8.9e-06	0.000391	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism—CAT—psoriasis	8.88e-06	0.00039	CbGpPWpGaD
Pravastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	8.59e-06	0.000377	CbGpPWpGaD
Pravastatin—ABCB11—Metabolism—PPARG—psoriasis	8.41e-06	0.00037	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—CARM1—psoriasis	8.29e-06	0.000364	CbGpPWpGaD
Pravastatin—ABCG2—Metabolism—CAT—psoriasis	8.22e-06	0.000361	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism—APOE—psoriasis	8.06e-06	0.000354	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—psoriasis	7.75e-06	0.000341	CbGpPWpGaD
Pravastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	7.57e-06	0.000333	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism of lipids and lipoproteins—APOE—psoriasis	7.24e-06	0.000318	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—CARM1—psoriasis	7.22e-06	0.000317	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism—PPARG—psoriasis	7.02e-06	0.000309	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism—APOE—psoriasis	6.9e-06	0.000303	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—CARM1—psoriasis	6.81e-06	0.000299	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—CARM1—psoriasis	6.75e-06	0.000296	CbGpPWpGaD
Pravastatin—ABCG2—Metabolism—APOE—psoriasis	6.39e-06	0.000281	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	6.31e-06	0.000277	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism—PPARG—psoriasis	6.01e-06	0.000264	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—CAT—psoriasis	5.89e-06	0.000259	CbGpPWpGaD
Pravastatin—ABCG2—Metabolism—PPARG—psoriasis	5.56e-06	0.000244	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—CAT—psoriasis	5.1e-06	0.000224	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—APOE—psoriasis	4.58e-06	0.000201	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—CARM1—psoriasis	4.45e-06	0.000196	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—CAT—psoriasis	4.44e-06	0.000195	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—CAT—psoriasis	4.19e-06	0.000184	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—CAT—psoriasis	4.15e-06	0.000182	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—PPARG—psoriasis	3.98e-06	0.000175	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—APOE—psoriasis	3.96e-06	0.000174	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—APOE—psoriasis	3.45e-06	0.000152	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—PPARG—psoriasis	3.45e-06	0.000152	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—APOE—psoriasis	3.25e-06	0.000143	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—APOE—psoriasis	3.23e-06	0.000142	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—PPARG—psoriasis	3.01e-06	0.000132	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—PPARG—psoriasis	2.83e-06	0.000125	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—PPARG—psoriasis	2.81e-06	0.000123	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—CAT—psoriasis	2.74e-06	0.00012	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—APOE—psoriasis	2.13e-06	9.35e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—PPARG—psoriasis	1.85e-06	8.14e-05	CbGpPWpGaD
